CORCEPT THERAPEUTICS INC
For the period ended Dec 31, 2024. Filed Feb 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 26, 2025
CORT$75.03+3.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net income | $141,209 | $106,140 | $101,418 |
| Other comprehensive income (loss): | |||
| Unrealized (loss) gain on available-for-sale investments, net of tax effect of $118, $(353), and $105, respectively | (598) | 1,120 | (331) |
| Foreign currency translation (loss) gain | (228) | 358 | (311) |
| Total comprehensive income | 140,383 | 107,618 | 100,776 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.